Dysfunction of the blood-cerebrospinal fluid-barrier and N-methyl-d-aspartate glutamate receptor antibodies in dementias

No abstract is available for this paper.

• Publication year

  2018

• Venue

  European Archives of Psychiatry and Clinical Neuroscience

• Publication date

  2018-08-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/s00406-017-0768-zPMID 28176002
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Anti-NMDA receptor encephalitis, autoimmunity, and psychosis.

  2016cited by this paper
• Anti-NMDA Receptor Encephalitis, Autoimmunity, and Psychosis.

  2016cited by this paper
• Herpes simplex infection and the risk of Alzheimer's disease: A nested case‐control study

  2015cited by this paper
• Reactivated herpes simplex infection increases the risk of Alzheimer's disease

  2015cited by this paper
• The brain as immunoprecipitator of serum autoantibodies against N‐Methyl‐D‐aspartate receptor subunit NR1

  2015cited by this paper
• N-methyl-d-aspartate glutamate receptor (NMDA-R) antibodies in mild cognitive impairment and dementias.

  2014cited by this paper
• N‐methyl‐D‐aspartate receptor antibodies in post–herpes simplex virus encephalitis neurological relapse

  2014cited by this paper
• Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood–brain barrier integrity

  2014cited by this paper
• Seroprevalence of autoantibodies against brain antigens in health and disease

  2014cited by this paper
• Apolipoprotein E4 carrier status plus circulating anti-NMDAR1 autoantibodies: association with schizoaffective disorder

  2014cited by this paper
• High prevalence of NMDA receptor IgA/IgM antibodies in different dementia types

  2014cited by this paper
• Seroprevalence of n-methyl-d-aspartate glutamate receptor (NMDA-R) autoantibodies in aging subjects without neuropsychiatric disorders and in dementia patients

  2014cited by this paper
• Cerebral ABC transporter-common mechanisms may modulate neurodegenerative diseases and depression in elderly subjects.

  2014cited by this paper
• Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis.

  2013cited by this paper
• IgA NMDA receptor antibodies are markers of synaptic immunity in slow cognitive impairment

  2012cited by this paper
• Anti-N-methyl-D-aspartate receptor encephalitis with serum anti-thyroid antibodies and IgM antibodies against Epstein-Barr virus viral capsid antigen: a case report and one year follow-up

  2011cited by this paper
• Anti-NMDA-receptor encephalitis: a severe, multistage, treatable disorder presenting with psychosis.

  2011cited by this paper
• Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis.

  2011cited by this paper
• Blood-brain barrier: ageing and microvascular disease--systematic review and meta-analysis.

  2009cited by this paper
• Anti-NMDA receptor encephalitis: report of ten cases and comparison with viral encephalitis

  2009cited by this paper
• Neuroexcitatory Targets in the Female Reproductive System of the Nonhuman Primate (Macaca fascicularis)

  2008cited by this paper
• NMDA receptor trafficking in synaptic plasticity and neuropsychiatric disorders

  2007cited by this paper
• The role of neuronal signaling in controlling cerebral blood flow.

  2007cited by this paper
• The excitotoxic effect of NMDA on human lymphocyte immune function.

  2007cited by this paper
• Role of the MEOX2 homeobox gene in neurovascular dysfunction in Alzheimer disease

  2005cited by this paper
• Human T lymphocytes express N-methyl-D-aspartate receptors functionally active in controlling T cell activation.

  2005cited by this paper
• Cognition and immunity; antibody impairs memory.

  2004cited by this paper
• The nature and effects of cortical microvascular pathology in aging and Alzheimer's disease

  2004cited by this paper
• Multiple panel of biomarkers for TIA/stroke evaluation.

  2002cited by this paper
• Cyclooxygenase‐2‐positive macrophages infiltrate the Alzheimer’s disease brain and damage the blood–brain barrier

  2002cited by this paper
• Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs.

  2001cited by this paper
• Serine proteases and brain damage - is there a link?

  2000cited by this paper
• Potential Target Sites in Peripheral Tissues for Excitatory Neurotransmission and Excitotoxicity

  2000cited by this paper
• Expression of Functional Metabotropic Glutamate Receptors in Primary Cultured Rat Osteoblasts

  2000cited by this paper
• Blood-brain barrier permeability of the demented elderly as studied by cerebrospinal fluid-serum albumin ratio.

  1998cited by this paper
• Blood brain barrier endothelial cells express candidate amyloid precursor protein-cleaving secretases.

  1998cited by this paper
• Viability thresholds and the penumbra of focal ischemia

  1994cited by this paper
• Blood‐brain‐barrier in a geriatric population: barrier function in degenerative and vascular dementias

  1991cited by this paper
• CSF and serum concentrations of albumin and IgG in Alzheimer's disease.

  1987cited by this paper
• CSF in Alzheimer's disease. Studies on blood-brain barrier function and intrathecal protein synthesis.

  1985cited by this paper
• [Rational histochemistry using a new microanalytic technic].

  1985cited by this paper
• Autoantibodies in highly aged humans.

  1984cited by this paper

• Neuronal autoantibodies in neurodegenerative dementia: From evidence to clinical framework.

  2026cites this paper
• Developing an Artificial Intelligence Framework for Identifying Fusion Blood-Based Biomarkers in Alzheimer's Disease

  2025cites this paper
• Blood–Brain Barrier Disruption in Schizophrenia: Insights, Mechanisms, and Future Directions

  2025cites this paper
• The role of autoantibodies in Alzheimer's disease: Pathogenetic connections or epiphenomena?

  2025cites this paper
• Longitudinally persisting KCNA2-autoantibodies in mild amnestic dementia with Alzheimer´s pathology - report and literature review.

  2025cites this paper
• Brain-targeting autoantibodies in patients with dementia

  2024cites this paper
• Advances in Plasma Biomarkers of Vascular Cognitive Impairment

  2024cites this paper
• ZeXieYin Formula alleviates TMAO-induced cognitive impairment by restoring synaptic plasticity damage.

  2023cites this paper
• Beyond the amyloid hypothesis: how current research implicates autoimmunity in Alzheimer’s disease pathogenesis

  2023cites this paper
• Neural Surface Antibodies and Neurodegeneration: Clinical Commonalities and Pathophysiological Relationships

  2023cites this paper
• Naringenin Attenuates Cognitive Impairment in a Rat Model of Vascular Dementia by Inhibiting Hippocampal Oxidative Stress and Inflammatory Response and Promoting N-Methyl-D-Aspartate Receptor Signaling Pathway

  2022cites this paper
• Neurobiological Highlights of Cognitive Impairment in Psychiatric Disorders

  2022cites this paper
• Dementia-associated changes of immune cell composition within the cerebrospinal fluid

  2021cites this paper
• Shenzhi Jiannao formula ameliorates vascular dementia in vivo and in vitro by inhibition glutamate neurotoxicity via promoting clathrin-mediated endocytosis

  2021cites this paper
• Association Between Homocysteine and Vitamin Levels in Demented Patients

  2021cites this paper
• Autoantibodies against the NMDAR subunit NR1 are associated with neuropsychiatric outcome after ischemic stroke.

  2021cites this paper
• Mitochondrial Protection and Against Glutamate Neurotoxicity via Shh/Ptch1 Signaling Pathway to Ameliorate Cognitive Dysfunction by Kaixin San in Multi-Infarct Dementia Rats

  2021cites this paper
• Neuronal surface autoantibodies in dementia: a systematic review and meta-analysis

  2020influential citation
• Blood-brain barrier regulation in psychiatric disorders.

  2020influential citation
• Cognitive impact of neuronal antibodies: encephalitis and beyond

  2020cites this paper
• Anti-N-methyl-d-aspartate receptor encephalitis in an older patient presenting with a rapid onset of delusions and amnesia

  2019cites this paper
• Potential Fluid Biomarkers for the Diagnosis of Mild Cognitive Impairment

  2019cites this paper
• Blood-Brain Barrier–Targeted Nanotechnological Advances

  2019cites this paper
• Role of Systemic Inflammation in Neurodegenerative Diseases

  2019cites this paper
• Biomarkers for Alzheimer’s disease: from pathogenesis to drug development

  2018cites this paper
• Choroid Plexus Blood-CSF Barrier: Major Player in Brain Disease Modeling and Neuromedicine

  2018cites this paper
• Antibodies to Multiple Receptors are Associated with Neuropsychiatric Symptoms and Mortality in Alzheimer’s Disease: A Longitudinal Study

  2018cites this paper
• Psychotic Symptoms Associated with Poor Renal Function in Mild Cognitive Impairment and Dementias

  2017cites this paper